Dr. Lal Pathlabs gets nod to acquire entire stake in Suburban Diagnostics

27 Oct 2021 Evaluate

Dr. Lal Pathlabs has received approval to acquire 100% stake in Suburban Diagnostics (India) from its existing shareholders. The objective of acquisition is to strengthen the Company’s presence in the western part of the country / State of Maharashtra. The board of directors at its meeting held on October 26, 2021 has approved the same.

Dr. Lal Pathlabs is a provider of diagnostic and related healthcare tests and services in India.

Dr. Lal Pathlabs Share Price

1470.50 -38.40 (-2.54%)
02-Jan-2026 12:23 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7104.40
Max Healthcare Inst 1059.85
Narayana Hrudayalay 1930.40
Aster DM Healthcare 608.85
Global Health 1208.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×